Testing effectiveness (Phase 2)Study completedNCT03565835
What this trial is testing
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Who this might be right for
Prostatic Neoplasms
Montefiore Medical Center 31